Share Capital and Warrants (Tables)
|
12 Months Ended |
Dec. 31, 2025 |
|---|
| Disclosure of significant unobservable inputs used in fair value measurement of liabilities [line items] |
|
| Summary of movements for the warrants outstanding |
| | | | | | | | | | | 2025 | | 2024 | | | | | Weighted | | | | Weighted | | | Number of | | average | | Number of | | average | | | Warrants | | exercise price | | Warrants | | exercise price | | | | | $ | | | | $ | Balance – Beginning of period | | 78,068,475 | | 7.17 | | 26,958,699 | | 12.93 | Issued – 2024 brokered private placement | | — | | — | | 31,946,366 | | 4.17 | Issued – 2024 non-brokered private placement | | — | | — | | 19,163,410 | | 4.07 | Issued – 2025 Financing Facility | | 5,625,031 | | 4.43 | | — | | — | Issued – 2025 Non-Brokered private placement | | 20,252,661 | | 3.53 | | — | | — | Issued – 2025 Brokered private placement | | 29,280,000 | | 3.53 | | — | | — | Warrants exercised | | (850,000) | | 4.14 | | — | | — | Balance – End of period | | 132,376,167 | | 5.71 | | 78,068,475 | | 7.17 |
|
| Schedule of outstanding warrants with maturity dates and exercise terms |
| | | | | | Placement | Classification | Maturity | Number of Warrants | Exercise Price | 2022 Brokered private placement | Equity | 02-Mar-27 | 7,752,916 | $ | 14.75 | 2022 Non-brokered private placement | Liability | 27-May-27 | 11,363,933 | US$ | 10.70 | 2023 Bought deal financing | Equity | 02-Mar-26 | 7,841,850 | $ | 8.55 | 2024 Non-brokered private placement | Liability | 01-Oct-29 | 19,163,410 | US$ | 3.00 | 2024 Brokered private placement | Liability | 01-Oct-29 | 31,096,366 | US$ | 3.00 | 2025 Financing facility | Equity | 21-Jul-28 | 5,625,031 | $ | 4.43 | 2025 Non-Brokered private placement | Liability | 15-Aug-27 | 20,252,661 | US$ | 2.56 | 2025 Brokered private placement | Liability | 15-Aug-27 | 29,280,000 | US$ | 2.56 |
|
| Schedule of Capital Management |
| | | | | | | 2025 | | 2024 | | | ($) | | ($) | Long-term debt | | 140,704 | | 45,817 | Total equity | | 682,689 | | 570,629 | Balance – End of period | | 823,393 | | 616,446 |
|
| 2024 Brokered private placement |
|
| Disclosure of significant unobservable inputs used in fair value measurement of liabilities [line items] |
|
| Summary of assumptions used to determine warrants exercisable |
| | | | Dividend per share | | | — | Expected volatility(i) | | | 81% | Risk-free interest rate | | | 4.3% | Expected life | | | 4.9 years | Exercise price (USD) | | | $3.00 | Share price (USD) | | | $1.58 |
| (i) | The expected volatility is estimated by benchmarking with companies having businesses similar to Osisko Development. The historical volatility of the common share price of these companies was used for benchmarking back from the date of grant and for a period corresponding to the expected life of the warrants. |
|
| 2024 Non-brokered private placement. |
|
| Disclosure of significant unobservable inputs used in fair value measurement of liabilities [line items] |
|
| Summary of assumptions used to determine warrants exercisable |
| | | | Dividend per share | | | — | Expected volatility(i) | | | 81% | Risk-free interest rate | | | 3.7% | Expected life | | | 5.0 years | Exercise price (USD) | | | $3.00 | Share price (USD) | | | $2.13 |
| (i) | The expected volatility is estimated by benchmarking with companies having businesses similar to Osisko Development. The historical volatility of the common share price of these companies was used for benchmarking back from the date of grant and for a period corresponding to the expected life of the warrants. |
|
| Private placement August 2025 |
|
| Disclosure of significant unobservable inputs used in fair value measurement of liabilities [line items] |
|
| Summary of assumptions used to determine warrants exercisable |
| | | | Dividend per share | | | 0% | Expected volatility (i) | | | 83.8% | Risk-free interest rate | | | 3.8% | Expected life | | | 1.67 | Exercise price (USD) | | | 2.56 | Share price (USD) | | | 2.58 | Fair value per warrant (USD) | | | 1.08 |
| (i) | The expected volatility is estimated by benchmarking with companies having businesses similar to Osisko Development. The historical volatility of the common share price of these companies was used for benchmarking back from the date of grant and for a period corresponding to the expected life of the warrants. |
|